DETAILED NOTES ON BI8622

In reports in which cerivastatin sodium has become administered concomitantly with cholestyramine, no adverse reactions special to this mix or Besides People previously described for this course of medicine had been claimed. Myopathy and rhabdomyolysis (with or devoid of acute renal failure) have already been noted when HMG-CoA reductase inhibitors